MA29809B1 - N-[1,3,4]-thiadiazol-2-yl-benzenesulfonamides,procedes pour leur preparation et leur utilisation en tant que produits pharmaceutiques - Google Patents
N-[1,3,4]-thiadiazol-2-yl-benzenesulfonamides,procedes pour leur preparation et leur utilisation en tant que produits pharmaceutiquesInfo
- Publication number
- MA29809B1 MA29809B1 MA30787A MA30787A MA29809B1 MA 29809 B1 MA29809 B1 MA 29809B1 MA 30787 A MA30787 A MA 30787A MA 30787 A MA30787 A MA 30787A MA 29809 B1 MA29809 B1 MA 29809B1
- Authority
- MA
- Morocco
- Prior art keywords
- disorders
- thiadiazol
- processes
- ppar
- benzenesulfonamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Abstract
L'INVENTION CONCERNE N-[1,3,4]-THIADIAZOL-2-YL-BENZÈNE SULFONAMIDES AINSI QUE DES SELS PHYSIOLOGIQUEMENT ACCEPTABLES ET DES DÉRIVÉS PHYSIOLOGIQUEMENT FONCTIONNELS DE CEUX-CI QUI EXERCENT UNE ACTIVITÉ AGONISTE SUR LES RÉCEPTEURS PPAR$G(D) ET LES RÉCEPTEURS PPAR$G(G). L'INVENTION DÉCRIT AINSI DES COMPOSÉS REPRÉSENTÉS PAR LA FORMULE (I), DANS LAQUELLE LES RADICAUX SONT TELS QUE DÉFINIS DANS LA DESCRIPTION, AINSI QUE LES SELS PHYSIOLOGIQUEMENT ACCEPTABLES DE CEUX-CI ET LES PROCÉDÉS UTILISÉS POUR LES OBTENIR. CES COMPOSÉS SONT UTILISÉS POUR TRAITER ET/OU PRÉVENIR LES TROUBLES DU MÉTABOLISME DES ACIDES GRAS, LES TROUBLES DE L'UTILISATION DU GLUCOSE, LES TROUBLES IMPLIQUANT L'INSULINORÉSISTANCE ET LA DÉMYÉLINISATION, AINSI QUE D'AUTRES TROUBLES NEURODÉGÉNÉRATIFS DU SYSTÈME NERVEUX CENTRAL ET PÉRIPHÉRIQUE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05021785 | 2005-10-06 | ||
PCT/EP2006/009301 WO2007039175A1 (fr) | 2005-10-06 | 2006-09-26 | N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides : procedes de preparation et utilisation comme produits pharmaceutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29809B1 true MA29809B1 (fr) | 2008-09-01 |
Family
ID=45219047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30787A MA29809B1 (fr) | 2005-10-06 | 2008-03-31 | N-[1,3,4]-thiadiazol-2-yl-benzenesulfonamides,procedes pour leur preparation et leur utilisation en tant que produits pharmaceutiques |
Country Status (17)
Country | Link |
---|---|
US (1) | US7858647B2 (fr) |
EP (1) | EP1937657A1 (fr) |
JP (1) | JP2009510147A (fr) |
KR (1) | KR20080050468A (fr) |
CN (1) | CN101282951A (fr) |
AR (1) | AR057145A1 (fr) |
AU (1) | AU2006299089A1 (fr) |
BR (1) | BRPI0616800A2 (fr) |
CA (1) | CA2624681A1 (fr) |
IL (1) | IL190461A0 (fr) |
MA (1) | MA29809B1 (fr) |
NO (1) | NO20081681L (fr) |
RU (1) | RU2008113211A (fr) |
TW (1) | TW200800929A (fr) |
UY (1) | UY29846A1 (fr) |
WO (1) | WO2007039175A1 (fr) |
ZA (1) | ZA200801987B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7994338B2 (en) | 2006-08-16 | 2011-08-09 | The J. David Gladstone Institutes | Small molecule inhibitors of kynurenine-3-monooxygenase |
EP2054056A4 (fr) * | 2006-08-16 | 2010-08-25 | J David Gladstone Inst A Testa | Petits inhibiteurs moleculaires de la kynurenine-3- monooxygenase |
EP2566853B1 (fr) | 2010-05-05 | 2017-01-25 | Infinity Pharmaceuticals, Inc. | Tétrazolones utilisés en tant qu'inhibiteurs d'acide gras synthase (fasn) |
WO2011140296A1 (fr) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles utilisés comme inhibiteurs d'acides gras synthase (fasn) |
RU2617988C2 (ru) | 2010-09-03 | 2017-05-02 | ФОРМА ТиЭм, ЭлЭлСИ | Новые соединения и композиции для ингибирования nampt |
CN102276554B (zh) * | 2011-06-28 | 2013-10-30 | 四川大学 | 4-((2-氨基-5-巯基-1,3,4-噻二唑)-甲基)-苯甲酰胺衍生物及其制备方法和用途 |
GB201810581D0 (en) | 2018-06-28 | 2018-08-15 | Ctxt Pty Ltd | Compounds |
JP7352662B2 (ja) | 2019-06-18 | 2023-09-28 | ファイザー・インク | ベンゾイソオキサゾールスルホンアミド誘導体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0301146A3 (en) * | 2000-04-28 | 2004-08-30 | Sankyo Co | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use |
WO2005005421A1 (fr) * | 2003-07-08 | 2005-01-20 | Novartis Ag | Composes benzenesulfonylamino, et compositions pharmaceutiques contenant ces composes |
-
2006
- 2006-09-26 KR KR1020087008144A patent/KR20080050468A/ko not_active Application Discontinuation
- 2006-09-26 CN CNA2006800369908A patent/CN101282951A/zh active Pending
- 2006-09-26 RU RU2008113211/04A patent/RU2008113211A/ru not_active Application Discontinuation
- 2006-09-26 AU AU2006299089A patent/AU2006299089A1/en not_active Abandoned
- 2006-09-26 CA CA002624681A patent/CA2624681A1/fr not_active Abandoned
- 2006-09-26 WO PCT/EP2006/009301 patent/WO2007039175A1/fr active Application Filing
- 2006-09-26 EP EP06792249A patent/EP1937657A1/fr not_active Withdrawn
- 2006-09-26 BR BRPI0616800-0A patent/BRPI0616800A2/pt not_active IP Right Cessation
- 2006-09-26 JP JP2008533907A patent/JP2009510147A/ja not_active Abandoned
- 2006-09-27 TW TW095135652A patent/TW200800929A/zh unknown
- 2006-10-04 AR ARP060104363A patent/AR057145A1/es not_active Application Discontinuation
- 2006-10-06 UY UY29846A patent/UY29846A1/es not_active Application Discontinuation
-
2008
- 2008-03-03 ZA ZA200801987A patent/ZA200801987B/xx unknown
- 2008-03-26 IL IL190461A patent/IL190461A0/en unknown
- 2008-03-31 MA MA30787A patent/MA29809B1/fr unknown
- 2008-04-04 US US12/062,764 patent/US7858647B2/en not_active Expired - Fee Related
- 2008-04-04 NO NO20081681A patent/NO20081681L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2008113211A (ru) | 2009-10-10 |
AU2006299089A1 (en) | 2007-04-12 |
US20090054494A1 (en) | 2009-02-26 |
UY29846A1 (es) | 2007-05-31 |
BRPI0616800A2 (pt) | 2011-06-28 |
KR20080050468A (ko) | 2008-06-05 |
TW200800929A (en) | 2008-01-01 |
WO2007039175A1 (fr) | 2007-04-12 |
US7858647B2 (en) | 2010-12-28 |
IL190461A0 (en) | 2008-11-03 |
ZA200801987B (en) | 2008-12-31 |
NO20081681L (no) | 2008-04-29 |
CN101282951A (zh) | 2008-10-08 |
JP2009510147A (ja) | 2009-03-12 |
CA2624681A1 (fr) | 2007-04-12 |
AR057145A1 (es) | 2007-11-21 |
EP1937657A1 (fr) | 2008-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29805B1 (fr) | Derives de phenyl-1.2.4-oxadiazolone, leurs procedes de preparation et leur utilisation comme produits pharmaceutiques | |
MA29807B1 (fr) | Dérives de phenyl-[1,2,4]- oxadiazol-5-one avec un groupement phényle, leurs procédés de préparation et leur utilisation comme produits pharmaceutiques. | |
MA29809B1 (fr) | N-[1,3,4]-thiadiazol-2-yl-benzenesulfonamides,procedes pour leur preparation et leur utilisation en tant que produits pharmaceutiques | |
MA30981B1 (fr) | Derives de sulfonyl-phenyl-2h-(1,2,4)oxadiazol-5-one, procedes de preparation associes et utilisation comme medicaments | |
MA32705B1 (fr) | Composes cycliques spiro-tetracycliques utiles en tant que modulateurs de la beta-secretase et leurs procedes d'utilisation | |
MA31865B1 (fr) | Dérivés isoxazolo-pyridine | |
MA29810B1 (fr) | 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzènesulfonamides, procédés pour leur préparation et leur utilisation en tant que produits pharmaceutiques | |
MA34898B1 (fr) | Nouveaux dérivés hétérocycliques et leur utilisation dans le traitement de troubles neurologiques | |
MA31857B1 (fr) | N-phenyl-pyrrolidinylmethylpyrrolidine-amides substitues et utilisation therapeutique de ceux -ci | |
TNSN04156A1 (fr) | Pyridinones substituees servant de modulateurs de la map-kinase p38 | |
MA31952B1 (fr) | Pyrrolopyrimidines et pyrrolopyridines | |
TNSN05104A1 (fr) | Derives de thiazole pour le traitement de troubles neurodegeneratifs | |
MA34361B1 (fr) | Dérivés de tétrahydro-pyrido-pyrimidine | |
MA30411B1 (fr) | Derives de triazolopyrazine utiles comme agent anticancereux | |
MA27448A1 (fr) | Derives de pyridine modulateurs du recepteur cb2 | |
MA27741A1 (fr) | Derives diarylcycloalkyles , procede pour leur production, et leur utilisation en tant que medicaments | |
TNSN05309A1 (fr) | Derives d'imidazole utilises comme antagonistes du recepteur du glutamate | |
MA30539B1 (fr) | Derives de piperazinyle utiles dans le traitement de maladies induites par le recepteur gpr38. | |
MA30720B1 (fr) | Analogues de 2-phenoxypyrimidinone | |
MA27852A1 (fr) | Derives de 1-(alkylaminoalkyl-pyrolidin-/piperidinyl)-2,2-diphenylacetamide utilises comme antagonistes du recepteur muscarinique | |
MA38012B1 (fr) | Dérivés d'éthynyle comme modulateurs de l'activité des récepteurs mglur5 | |
TN2010000025A1 (fr) | Derives de l'indol -2-one disubstitues en 3, leur preparation et leur application en therapeutique | |
MA46342A (fr) | Dérivés de chromane, d'isochromane et de dihydroisobenzofurane en tant que modulateurs allostériques négatifs de mglur2, compositions et leur utilisation | |
TNSN07366A1 (fr) | Tetrahydro-pyridoazepine -8- ones et composes apparentes, pour le traitement de la schizophrenie | |
MA29812B1 (fr) | N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides cycliques, procedes pour leur preparation et leur utilisation en tant que substances pharmaceutiques |